science
informative
local

New York City reports first severe mpox case with no known local transmission

Mar 16, 2026, 4:12 PM10
(Update: Mar 16, 2026, 4:12 PM)
most populous city in the United States
Irish cyclist

New York City reports first severe mpox case with no known local transmission

  • First case of severe mpox clade I confirmed in New York City by NYC Health Department.
  • The individual is believed to have contracted it through travel, with no local transmission known.
  • Health officials emphasize that the risk to local residents remains low, recommending vaccination for at-risk groups.
Share your opinion
1

Story

In New York City, the first case of severe mpox clade I has been reported, marking a significant health concern as this variant is associated with more severe symptoms and potential life-threatening complications. The NYC Health Department has confirmed that one resident tested positive for this variant, which is one of the two main genetic groups of the mpox virus. According to Dr. Marc Siegel, a Fox News senior medical analyst, the lack of known local transmission suggests that the case likely originated from travel. He emphasized the importance of understanding that although this variant can cause serious illness, the survival rate exceeds 99.9%. This information brings some comfort amid the alert regarding the transmission of mpox, especially in gay and bisexual communities where the risk is more pronounced. Public health officials have stated that mpox clade I spreads primarily through direct contact, including sexual contact, and close respiratory droplets, rather than through respiratory spread over longer distances. The NYC Health Commissioner, Dr. Alister Martin, reassured residents that the overall risk remains low for New Yorkers, highlighting that no local transmission networks have been identified. He urged those at risk, particularly individuals in certain demographics, to consider vaccination against mpox as a precautionary measure. The CDC recommends vaccination for men who are gay, bisexual, or have sex with men, individuals aged 18 or older, and those planning to travel to areas with active mpox clade I cases. The two-dose JYNNEOS vaccine remains the most common preventive measure available. Symptoms of mpox include a painful, blistery rash, fever, chills, exhaustion, muscle aches, headache, and swollen lymph nodes, typically emerging one to three weeks after exposure. In rare instances, mpox can lead to severe complications, including eye infections or neurological problems. Treatment generally involves supportive care to manage symptoms, while antiviral medications, such as TPOXX (tecovirimat), are reserved for more severe cases. As authorities monitor the situation, they continue to prioritize public health measures aimed at preventing further spread. This includes educating the public about the importance of vaccination, what symptoms to watch for, and the necessity of prompt medical attention if symptoms do occur. Continued vigilance will be crucial in managing the potential impact of this case as well as the broader context of mpox in New York City and beyond.

2026 All rights reserved